Literature DB >> 4363398

Limitations of immunofluorescence tests in the diagnosis of infectious mononucleosis.

J H Joncas, J C Gilker, A Chagnon.   

Abstract

The relative value of heterophil agglutinins (HA) and of specific EBV antibodies in the diagnosis of infectious mononucleosis (IM) was assessed in 108 cases of the disease and in 280 controls. Among the 108 cases 93 were HA-positive by sheep cells in at least one of their sera, while 15 were HA-negative by the same test. Among the 280 controls false-positive HA tests were not encountered except in eight cases with the horse cell microtitre tests. With one of the two slide tests at least two false-positive tests and 12 false-negative tests were also found but these sera had low titres in microtitre tests. The HA life-span was found to be unexpectedly long in a few cases, sheep cell HA lasting up to 8 to 10 months and horse cell HA up to 21 to 23 months.Many false-positive tests may therefore not be true false-positives and may result from the persistence of HA following unrecognized mononucleosis months before. Virtually all cases of IM had (or developed) antibodies to Epstein-Barr virus, viral capsid antigen (EBV-VCA), whereas only half of the controls were EBV-VCA-positive. The comparative analysis of nonspecific and specific test results in mononucleosis allows the following conclusions: (1) horse cell microtitre tests and the monospot test are more sensitive than sheep cell microtitre tests and the monotest; (2) false-negative results are occasionally seen with the latter tests but not with the former; (3) more false-positive results, however, are probably seen with the former tests; and (4) specific EBV-IgM and EBV-EA antibody tests are useful in the diagnosis of selected borderline cases of mononucleosis.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4363398      PMCID: PMC1947468     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  24 in total

1.  Antibodies in human sera to soluble and viral antigens found in Burkitt lymphoma and other lymphoblastoid cell lines.

Authors:  V Vonka; M Benyesh-Melnick; R M McCombs
Journal:  J Natl Cancer Inst       Date:  1970-04       Impact factor: 13.506

2.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

3.  Cytomegalovirus mononucleosis in previously healthy individuals. Five new cases and follow-up of 13 previously published cases.

Authors:  E Klemola; R von Essen; O Wager; K Haltia; A Koivuniemi; I Salmi
Journal:  Ann Intern Med       Date:  1969-07       Impact factor: 25.391

4.  Significance of a complement-fixing antigen associated with herpes-like virus and detected in the Raji cell line.

Authors:  J H Pope; M K Horne; E J Wetters
Journal:  Nature       Date:  1969-04-12       Impact factor: 49.962

5.  Further studies on cytomegalovirus mononucleosis in previously healthy individuals.

Authors:  E Klemola; L Kääriäinen; R von Essen; K Haltia; A Koivuniemi; C H von Bonsdorff
Journal:  Acta Med Scand       Date:  1967-09

6.  Observations on the nature of the herpes-type EB virus in cultured Burkitt lymphoblasts, using a specific immunofluorescence test.

Authors:  M A Epstein; B G Achong
Journal:  J Natl Cancer Inst       Date:  1968-03       Impact factor: 13.506

7.  Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis.

Authors:  E Klemola; L Kääriäinen
Journal:  Br Med J       Date:  1965-11-06

8.  Seroepidemiologic studies of infectious mononucleosis with EB virus.

Authors:  A S Evans; J C Niederman; R W McCollum
Journal:  N Engl J Med       Date:  1968-11-21       Impact factor: 91.245

9.  Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies.

Authors:  J C Niederman; R W McCollum; G Henle; W Henle
Journal:  JAMA       Date:  1968-01-15       Impact factor: 56.272

10.  Horse agglutinins in infectious mononueleosis. 3. riterion for differential diagnosis.

Authors:  C L Lee; F Zandrew; I Davidsohn
Journal:  J Clin Pathol       Date:  1968-09       Impact factor: 3.411

View more
  2 in total

1.  Improved Epstein-Barr virus immunoglobulin M antibody test.

Authors:  J H Joncas; M Granger-Julien; F Gervais
Journal:  J Clin Microbiol       Date:  1975-02       Impact factor: 5.948

2.  Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.

Authors:  J H Joncas; A Wills; E Reece; Z Fox
Journal:  Can Med Assoc J       Date:  1981-10-15       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.